Aldeyra Therapeutics, Inc.Aldeyra Therapeutics, Inc.Aldeyra Therapeutics, Inc.

Aldeyra Therapeutics, Inc.

No trades
See on Supercharts

Price target

10.290.000.00%
The 7 analysts offering 1 year price forecasts for ALDX have a max estimate of — and a min estimate of —.

Analyst rating

Based on 7 analysts giving stock ratings to ALDX in the past 3 months.

EPS

Reported
Estimate
Reported
Estimate
Surprise

Revenue

Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


ALDX EPS for the last quarter is −0.25 USD despite the estimation of −0.25 USD. In the next quarter EPS is expected to reach −0.24 USD. Track more of Aldeyra Therapeutics, Inc. financials and stay on top of what is up with the company.
In the next quarter Aldeyra Therapeutics, Inc. revenue is expected to reach ‪19.80 M‬ USD. Check out Aldeyra Therapeutics, Inc. revenue and earnings and make informed decisions.
According to analysts, ALDX price target is 10.29 USD with a max estimate of 12.00 USD and a min estimate of 8.00 USD. Check if this forecast comes true in a year, meanwhile watch Aldeyra Therapeutics, Inc. stock price chart and keep track of the current situation with ALDX news and stock market news.
We've gathered opinions of 7 analysts rating ALDX stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as strong buy. Note that it's not a trading advice — your own analysis is still required.